MX9102684A - Metodo para construir secuencias de peptido lider, sinteticas. - Google Patents

Metodo para construir secuencias de peptido lider, sinteticas.

Info

Publication number
MX9102684A
MX9102684A MX9102684A MX9102684A MX9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A
Authority
MX
Mexico
Prior art keywords
lider
peptido
synthetics
build sequences
build
Prior art date
Application number
MX9102684A
Other languages
English (en)
Inventor
Lars Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9102684A publication Critical patent/MX9102684A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Consolidation Of Soil By Introduction Of Solidifying Substances Into Soil (AREA)
  • Building Environments (AREA)
  • Working Measures On Existing Buildindgs (AREA)
  • Prevention Of Electric Corrosion (AREA)
  • Bridges Or Land Bridges (AREA)
MX9102684A 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas. MX9102684A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Publications (1)

Publication Number Publication Date
MX9102684A true MX9102684A (es) 1992-06-01

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102684A MX9102684A (es) 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas.

Country Status (17)

Country Link
EP (1) EP0563175A1 (es)
JP (1) JPH06503957A (es)
KR (1) KR930703450A (es)
AU (1) AU660161B2 (es)
CA (1) CA2098731A1 (es)
CZ (1) CZ119293A3 (es)
DK (1) DK300090D0 (es)
FI (1) FI932831A0 (es)
HU (1) HUT68751A (es)
IE (1) IE914433A1 (es)
IL (1) IL100408A0 (es)
MX (1) MX9102684A (es)
NZ (1) NZ241011A (es)
PT (1) PT99848A (es)
SK (1) SK62593A3 (es)
WO (1) WO1992011378A1 (es)
ZA (1) ZA919932B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
ZA954983B (en) * 1994-06-17 1996-02-14 Novo Nordisk As N-terminally extended proteins expressed in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
WO1996029397A1 (en) 1995-03-17 1996-09-26 Novo Nordisk A/S Novel endoglucanases
CZ297338B6 (cs) 1996-03-01 2006-11-15 Novo Nordisk A/S Peptid potlacující chut k jídlu, farmaceutický prostredek jej obsahující a jeho pouzití
WO1998025963A1 (en) 1996-12-13 1998-06-18 Chiron Corporation Analysis and separation of platelet-derived growth factor proteins
JP2003525570A (ja) 1998-01-23 2003-09-02 ノボ ノルディスク アクティーゼルスカブ 酵母において所望のポリペプチドを産生する方法
KR20030004315A (ko) 1999-12-29 2003-01-14 노보 노르디스크 에이/에스 효모에서 개선된 발효 수율을 갖는 인슐린 선구물질 및인슐린 선구물질 유사체의 제조 방법
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
CZ20032454A3 (en) 2001-03-22 2004-03-17 Novo Nordisk Health Care Ag Coagulation factor vii derivative
ES2376694T3 (es) 2001-09-27 2012-03-16 Novo Nordisk Health Care Ag Polipã‰ptidos del factor vii de coagulaciã“n humano.
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
EP1687428A1 (en) 2003-11-14 2006-08-09 Novo Nordisk A/S Processes for making acylated insulin
JP5697831B2 (ja) 2003-12-03 2015-04-08 ノヴォ ノルディスク アー／エス 単鎖インシュリン
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
BRPI0609079A2 (pt) 2005-04-18 2010-11-16 Novo Nordisk As peptìdeo, composição farmacêutica, método para o tratamento de cáncer, uso de um peptìdeo construto de ácido nucleico, vetor, hospedeiro, e, anticorpo
CN101243190B (zh) 2005-08-16 2015-05-13 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
JP5690047B2 (ja) 2005-09-14 2015-03-25 ノボ ノルディスク ヘルス ケア アーゲー ヒト凝固第ｖｉｉ因子ポリペプチド
DE602007009496D1 (de) 2006-02-27 2010-11-11 Novo Nordisk As Insulinderivate
US8518668B2 (en) 2006-09-27 2013-08-27 Novo Nordisk A/S Method for making maturated insulin polypeptides in a fungal cell
ES2558930T3 (es) 2007-08-13 2016-02-09 Novo Nordisk A/S Análogos de la insulina de acción rápida
KR20100053561A (ko) 2007-08-15 2010-05-20 노보 노르디스크 에이/에스 아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
CN101784563B (zh) 2007-08-15 2015-02-04 诺沃-诺迪斯克有限公司 具有包括含亚烷基二醇的氨基酸的重复单位的酰基部分的胰岛素
US20120107267A1 (en) 2009-03-11 2012-05-03 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
US20120282285A1 (en) 2009-07-17 2012-11-08 Rigshospitalet Masp isoforms as inhibitors of complement activation
CN102639559B (zh) 2009-11-25 2015-04-29 诺沃—诺迪斯克有限公司 用于制备多肽的方法
JP5931738B2 (ja) 2009-12-01 2016-06-08 ノヴォ ノルディスク アー／エス 新規のペプチジルアルファ−ヒドロキシグリシンアルファ−アミド化リアーゼ
EP2526117B1 (en) 2010-01-22 2015-05-06 Novo Nordisk A/S Process for preparing fgf-21 with low degree of o-glycosylation
AU2011222883B2 (en) 2010-03-05 2016-05-26 Omeros Corporation Chimeric inhibitor molecules of complement activation
WO2012015692A2 (en) * 2010-07-28 2012-02-02 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
ES2676029T3 (es) 2012-02-09 2018-07-16 Var2 Pharmaceuticals Aps Direccionamiento de glicanos de sulfato de condroitina
EP2906693A1 (en) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Coagulation factor vii polypeptides
JP2016521701A (ja) 2013-06-07 2016-07-25 ノヴォ ノルディスク アー／エス 成熟インスリンポリペプチドを作製するための方法
CN120060321A (zh) * 2014-02-28 2025-05-30 诺和诺德股份有限公司 交配因子α原肽变体
EP3821244A1 (en) 2018-07-13 2021-05-19 Varct Diagnostics ApS Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
KR100195632B1 (ko) * 1988-07-23 1999-06-15 스티븐 조지 가랜드 펩티드 및 dna 배열
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
NZ241011A (en) 1993-04-28
WO1992011378A1 (en) 1992-07-09
IE914433A1 (en) 1992-07-01
FI932831A7 (fi) 1993-06-18
CA2098731A1 (en) 1992-06-19
IL100408A0 (en) 1992-09-06
JPH06503957A (ja) 1994-05-12
FI932831L (fi) 1993-06-18
SK62593A3 (en) 1993-10-06
HU9301801D0 (en) 1993-10-28
KR930703450A (ko) 1993-11-30
FI932831A0 (fi) 1993-06-18
HUT68751A (en) 1995-07-28
DK300090D0 (da) 1990-12-19
AU660161B2 (en) 1995-06-15
AU9134891A (en) 1992-07-22
ZA919932B (en) 1992-08-26
EP0563175A1 (en) 1993-10-06
CZ119293A3 (en) 1994-02-16
PT99848A (pt) 1993-06-30

Similar Documents

Publication Publication Date Title
MX9102684A (es) Metodo para construir secuencias de peptido lider, sinteticas.
DZ1798A1 (fr) Nouveaux composés.
FI956168A7 (fi) Uudet kemialliset yhdisteet, joilla on PDE-IV:ää inhiboivaa aktiivisuu tta
ES548388A0 (es) Un procedimiento para la preparacion de un peptido.
MX9203870A (es) Metodo para la produccion de granulos.
DE69530681D1 (de) (4,4-difluorbut-3-enylthio)-substituierte heterocyckische oder carbocyclische ring-verbindungen mit pesticider wirkung
DE69206512D1 (de) Herstellungsverfahren von Hartfetten.
BR9106139A (pt) Solucao catalisadora de paladio aquosa,processo wacker para fabricacao de acetaldeido,processo para oxidacao de olefina,e processo para oxidacao de vanadio (iv)
MX9206450A (es) Proceso para la produccion de isoleucina-l.
DK0613839T3 (da) Aksialt sammensat, delt kædehjulssamling
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
MX9203075A (es) Nuevos compuestos de enzotiofeno y benzofurano.
MX9206442A (es) Metodo para el aumento de la produccion de larvas de crustaceos.
DE69431992D1 (de) Verbessertes, telomerisiertes ölprodukt
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
PL322542A1 (en) Method of obtaining isomers of (r)-and (s)-alpha-methyl-3-(trifluoromethyl)benzene dimethylamine
BR8901036A (pt) Compostos,processo para sua preparacao,bem como sua aplicacao
MX9200841A (es) Proceso mejorado para la preparacion de dinitrotolueno.
ES522559A0 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
FI951277L (fi) Uudet N,N,N',N'-tetrasubstituoituneet 1,2-etaanidiamiinijohdannaisyhdisteet
ITTO930806A0 (it) Purificazione dell' 1,1-dicloro-1-fluoroetano.
BR9107188A (pt) Processo para nitração contínua de compostos aromáticos nitráveis.
MX9207468A (es) Proceso para preparar acido 2,6-naftalenodicarboxilico purificado.
FR2655308B1 (fr) Bicyclette de haute performance.
ES2021048B3 (es) Un metodo para la preparacion de un derivado de 2,4-diamino-3oxi-pirimidina.